SKYRIZI is available as
a single 150 mg injection1

SKYRIZI® prefilled syringe.

SKYRIZI is the only 4-dose-a-year biologic for Ps and for PsA that offers a single-dose pen1


SKYRIZI is also available in a single-dose 150 mg/mL prefilled syringe.1

Scroll to see more

Discover the 150 mg/mL SKYRIZI PEN1-3

What stays the same with the SKYRIZI Pen1-3

Same SKYRIZI you
know and trust,
in a single
150 mg/mL injection*

Consistent efficacy
and safety profile

In-office or at-home
administration after
proper training

*Bioequivalence was demonstrated between a single 150 mg/mL injection and two 75 mg/0.83 mL injections in a prefilled syringe.
Bioequivalence was also demonstrated between 150 mg/mL prefilled syringe and prefilled pen.

SKYRIZI is intended for use under the guidance and supervision of a healthcare professional. Patients may self-inject SKYRIZI after
training in subcutaneous injection technique.1

GREEN ACTIVATOR BUTTON

Audibly clicks to indicate start and end of injection

INSPECTION WINDOW

Allows for viewing medication and confirming injection is complete (via yellow indicator)

GRAY HAND GRIPS

DARK GRAY CAP

Covers hidden needle with
automatic needle guard

WHITE NEEDLE SLEEVE
(BENEATH THE CAP)

Hides needle from view

THE RESULTS ARE IN

In a questionnaire from a single-arm, open-label study, patients reported a
positive injection experience3,4

AT WEEK 28

98% (n=81/83) OF PATIENTS REPORTED

EASE OF USE

SKYRIZI Pen was
easy/very easy to use

CONVENIENCE

SKYRIZI Pen was
convenient/very convenient

SATISFACTION

They were satisfied/very
satisfied self-injecting
with the SKYRIZI Pen

DESCRIPTION: In an open-label, single-arm, multicenter study evaluating the SKYRIZI Pen (N=108), patient experience was reported through questions within 6 domains of a validated Self-Injection Assessment Questionnaire (SIAQ). Graphic includes percent of patients reporting easy/very easy, convenient/very convenient, satisfied/very satisfied for 3 questions within the ease of use and satisfaction domains at Week 28 (N=83).3,4

ADMINISTRATION INSTRUCTIONS: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional. Patients may self-inject SKYRIZI after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injection technique of SKYRIZI according to the

.1